Iovance Biotherapeutics Stock Price - IOVA

7.13 (28.88%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
7.13 28.88% 31.82 24.53 34.46 24.81 24.69 14:14:42
Bid Price Ask Price Spread Spread % News
31.81 31.89 0.08 0.25% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
44,606 7,737,481 $ 27.42 $ 212,163,617 1,049,788 9.21 - 34.46
Last Trade Time Type Quantity Stock Price Currency
14:14:42 100 $ 31.82 USD

Iovance Biotherapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.65B 126.19M $ -123.58M -1.27 - 105.42M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Iovance Biotherapeutics News

Loading Messages....

Latest IOVA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IOVA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week23.8234.4623.58525.011,254,1728.0033.59%
1 Month21.7234.4620.9323.77866,51310.1046.5%
3 Months22.4334.4620.9325.411,184,7459.3941.86%
6 Months19.8734.4617.6722.761,205,08911.9560.14%
1 Year10.0134.469.2119.631,375,41221.81217.88%
3 Years7.2034.464.4515.241,014,25724.62341.94%
5 Years8.5734.464.2413.83765,48823.25271.3%

Iovance Biotherapeutics Description

Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient.

Your Recent History
Iovance Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.